Free Trial
NASDAQ:NURO

NeuroMetrix (NURO) Stock Price, News & Analysis

NeuroMetrix logo
$4.55 +0.19 (+4.36%)
Closing price 05/1/2025
Extended Trading
$4.55 0.00 (0.00%)
As of 05/1/2025 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About NeuroMetrix Stock (NASDAQ:NURO)

Key Stats

Today's Range
$4.33
$4.69
50-Day Range
$4.55
$4.55
52-Week Range
$2.66
$4.73
Volume
35,522 shs
Average Volume
16,783 shs
Market Capitalization
$9.37 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive NURO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NeuroMetrix and its competitors with MarketBeat's FREE daily newsletter.

NURO Stock News Headlines

3..2..1.. AI 2.0 ignition (don’t sleep on this)
I just put together an urgent new presentation that you need to see right away. In short: I believe we are mere days away from a critical announcement from a key tech leader… One that will officially ignite “AI 2.0” – and potentially send a whole new class of stocks soaring.
Neurometrix Announces Board Changes for 2024
See More Headlines

NURO Stock Analysis - Frequently Asked Questions

NeuroMetrix's stock was trading at $3.97 on January 1st, 2025. Since then, NURO stock has increased by 14.6% and is now trading at $4.55.

NeuroMetrix, Inc. (NASDAQ:NURO) posted its quarterly earnings data on Tuesday, November, 5th. The medical device company reported ($0.75) earnings per share (EPS) for the quarter. The medical device company earned $0.59 million during the quarter. NeuroMetrix had a negative trailing twelve-month return on equity of 42.56% and a negative net margin of 203.71%.

NeuroMetrix's stock reverse split on the morning of Wednesday, November 22nd 2023.The 1-8 reverse split was announced on Monday, November 20th 2023. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, November 21st 2023. An investor that had 100 shares of stock prior to the reverse split would have 13 shares after the split.

Shares of NURO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that NeuroMetrix investors own include AMC Entertainment (AMC), NIO (NIO), Digital World Acquisition (DWAC), Meta Platforms (META), Advanced Micro Devices (AMD), Pfizer (PFE) and Tesla (TSLA).

Company Calendar

Last Earnings
11/05/2024
Today
7/14/2025
Next Earnings (Estimated)
8/04/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:NURO
CIK
1289850
Employees
20
Year Founded
1996

Profitability

EPS (Trailing Twelve Months)
($4.59)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$6.53 million
Net Margins
-203.71%
Pretax Margin
-203.69%
Return on Equity
-42.56%
Return on Assets
-39.26%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
13.88
Quick Ratio
12.70

Sales & Book Value

Annual Sales
$3.03 million
Price / Sales
3.09
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$13.18 per share
Price / Book
0.35

Miscellaneous

Outstanding Shares
2,060,000
Free Float
1,903,000
Market Cap
$9.37 million
Optionable
Not Optionable
Beta
1.82

Social Links

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NASDAQ:NURO) was last updated on 7/14/2025 by MarketBeat.com Staff
From Our Partners